drugset / Trial / NCT05573477
Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate safety and efficacy of ATB-1011 and ATB-1012 co-administration in patients with essential hypertension and type II diabetes mellitus
Timeline
- Start
- 2022-11-16
- Primary completion
- 2024-01
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATB-1011 | Unknown | — | Oral |
| Subject | ATB-1012 | Unknown | — | Oral |
| Subject | ATB-1013 | Unknown | — | Oral |